Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,941 to 1,960 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between DNA damage repair gene somatic mutations and immune-related gene expression in ovarian cancer. | Cancer Med | 2020 | 31991061 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Arsenic-Induced Disruption of DNA Repair. | Chem Res Toxicol | 2020 | 31986875 | PubTator, text mining | PubMed |
| Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline. | J Clin Oncol | 2020 | 31986064 | PubTator, text mining | PubMed |
| Fanconi anemia and the underlying causes of genomic instability. | Environ Mol Mutagen | 2020 | 31983075 | PubTator, text mining | PubMed |
| Population Frequency of Fanconi Pathway Gene Variants and Their Association with Survival After Hematopoietic Cell Transplantation for Severe Aplastic Anemia. | Biol Blood Marrow Transplant | 2020 | 31982544 | PubTator, text mining | PubMed |
| Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair. | Nucleic Acids Res | 2020 | 31980815 | PubTator, text mining | PubMed |
| Mitoprotective Clinical Strategies in Type 2 Diabetes and Fanconi Anemia Patients: Suggestions for Clinical Management of Mitochondrial Dysfunction. | Antioxidants (Basel) | 2020 | 31963742 | PubTator, text mining | PubMed |
| Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience. | Cancers (Basel) | 2020 | 31963545 | PubTator, text mining | PubMed |
| HSF2BP negatively regulates homologous recombination in DNA interstrand crosslink repair. | Nucleic Acids Res | 2020 | 31960047 | PubTator, text mining | PubMed |
| Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer. | Cancer Sci | 2020 | 31958182 | PubTator, text mining | PubMed |
| Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. | J Clin Immunol | 2020 | 31953710 | PubTator, text mining | PubMed |
| Mitochondrial DNA variations and mitochondrial dysfunction in Fanconi anemia. | PLoS One | 2020 | 31940411 | PubTator, text mining | PubMed |
| Challenges in reporting pathogenic/potentially pathogenic variants in 94 cancer predisposing genes - in pediatric patients screened with NGS panels. | Sci Rep | 2020 | 31937788 | PubTator, text mining | PubMed |
| DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia. | Gut | 2020 | 31937549 | PubTator, text mining | PubMed |
| Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report. | Diagn Pathol | 2020 | 31931827 | PubTator, text mining | PubMed |
| Bio-AnswerFinder: a system to find answers to questions from biomedical texts. | Database (Oxford) | 2020 | 31925435 | PubTator, text mining | PubMed |
| Implementation and use of whole exome sequencing for metastatic solid cancer. | EBioMedicine | 2020 | 31923800 | PubTator, text mining | PubMed |
| Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort. | Cancer | 2020 | 31923330 | PubTator, text mining | PubMed |
| Fanconi Anemia DNA Repair Pathway as a New Mechanism to Exploit Cancer Drug Resistance. | Mini Rev Med Chem | 2020 | 31902358 | PubTator, text mining | PubMed |
| PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes. | iScience | 2020 | 31884170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=98